Paul Stamets Psilocybin Mushrooms and The Mycology of Consciousness
01:07:43 min
CLEAR ALL
Badass women making waves in the psychedelic movement, from research to drug policy reform.
1
Though researchers are still trying to understand the cognitive and therapeutic mechanics of psychedelics, they have concluded that psilocybin, DMT and other psychoactive chemicals can help people feel more tolerance, understanding and empathy.
2
While we can now begin to glimpse an end to the drug war, it is much harder to envision what the drug peace will look like. How will we fold these powerful substances into our society and our lives so as to minimize their risks and use them most constructively?
The exuberant “renaissance” of studies researching psychedelic-assisted psychotherapy in the past twenty years has not sufficiently included the enrollment of racially diverse participants, a problem that psychedelic science and clinical research shares with mainstream psychiatry
Amazonian healing traditions collide with Western medical sensibilities.
A new review of studies finds that LSD, psilocybin, and MDMA hold potential for treating mental illness.
Now, as a handful of patients and more recently doctors and therapists have been granted exemptions to use psilocybin, the nation’s federal health agency is considering making changes to existing policies that could open the door to much more than magic mushrooms.
Those of us who are professional counselors are perhaps most likely to recognize psychedelic drugs by their recreational or street names — acid, magic mushrooms, ecstasy — and to consider them to be drugs of abuse that may be dangerous to our clients.
Roland Griffiths' psilocybin experiments have produced striking evidence for therapeutic uses of hallucinogens.
A new generation of research into psilocybin could change how we treat numerous mental health conditions.